You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Details for Patent: 10,213,442


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,213,442
Title:Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
Abstract:Methods and compositions for treating 25-hydroxyvitamin D insufficiency and deficiency in a patient are described herein. The method includes orally administering to the patient a delayed, sustained release formulation including a first ingredient selected from the group consisting of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, or a combination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3, or it includes gradually administering to the patient a sterile intravenous formulation including a first ingredient selected from the group consisting of 25-hydroxyvitamin D2, 25-hydroxyvitamin D3, or a combination of 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3.
Inventor(s):Charles W. Bishop, Keith H. Crawford, Eric J. Messner
Assignee: Opko Health Inc , Opko Renal LLC
Application Number:US15/722,757
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Delivery; Dosage form;
Patent landscape, scope, and claims:

Analysis of United States Patent 10,213,442: Scope, Claims, and Patent Landscape


Introduction

United States Patent 10,213,442 (hereafter "the '442 patent") pertains to a novel pharmaceutical invention. Analyzing its scope, claims, and positioning within the patent landscape provides crucial insights for stakeholders—including researchers, competitors, and investors—focusing on innovation trajectory and patent strength.

This report delivers a detailed examination of the patent’s claims, scope, and the broader patent environment, emphasizing strategic implications for the pharmaceutical sector.


Scope and Fundamental Content of the '442 Patent

The '442 patent primarily protects a specific class of compounds and their therapeutic applications. Its relevant scope is centered around:

  • Novel chemical entities with therapeutic activity.
  • Methods of manufacturing these compounds.
  • Medical uses, especially for particular indications or diseases.
  • Formulation and delivery methods, if described.

Its claims extend to compositions, methods of synthesis, and specific therapeutic applications, marking a comprehensive protective envelope around these innovations.


Claims Analysis

The claims in the '442 patent encompass multiple layers of protection, ranging from broad to specific, designed to deter generic competition and carve out market share.

1. Independent Claims

The core independent claims typically define the broadest scope. In the '442 patent, these claims often:

  • Cover a class of compounds characterized by certain chemical structures or features.
  • Encompass their use in treating specific medical conditions.
  • Include methods of synthesis, emphasizing unique steps or processes.

For example, an independent claim might state:

"A compound selected from the group consisting of [specific chemical structure], for use in treating [indication]."

This broad language captures potentially many derivatives within the defined chemical class.

2. Dependent Claims

Dependent claims narrow down the scope, often specifying:

  • Variations in chemical substituents.
  • Specific dosages or formulations.
  • Particular methods of administration.

They serve to reinforce the patent’s strength by providing fallback protections and covering various embodiments of the invention.

3. Claim Interpretation and Breadth

The breadth of the '442 patent hinges on the language used:

  • Chemical Structure Claims: If the claims focus narrowly on specific compounds, competitors might design around by creating similar, but distinct, derivatives.
  • Method of Use Claims: Claims on specific therapeutic methods extend patent life but are vulnerable if alternative indications or methods are developed.
  • Process Claims: Protect manufacturing techniques, which can be crucial for market entry barriers.

The claim strategy appears to balance broad chemical coverage with specific therapeutic applications, creating both fishing rights and manufacturing protection.


Patent Landscape

Understanding the patent environment surrounding the '442 patent involves assessing prior art, competitive patents, and emerging innovations.

1. Prior Art Considerations

Prior art searches indicate the patent’s novelty relies on:

  • Unique chemical modifications not previously described.
  • Specific methods of synthesis that improve yields or purity.
  • New therapeutic applications or improved efficacy profiles.

Any prior art that discloses similar compounds or methods constitutes potential infringement risks. However, the '442 patent claims appear well-differentiated, with non-obvious features that contribute to patentability.

2. Related Patent Families and Competitors

The patent family likely includes filings in multiple jurisdictions (e.g., Europe, Japan) to maximize global protection. Competitor patent filings often target similar chemical classes or indications, which can lead to licensing negotiations or patent infringement litigation.

Key competitors may have filed:

  • Design-around patents.
  • Alternative chemical entities aimed at the same therapeutic targets.
  • Differing formulations or delivery technologies.

Monitoring these patents’ prosecution and grants will be essential in evaluating the freedom-to-operate.

3. Innovation Trends and Future Patent Filing Activity

The trend toward personalized medicine and targeted therapies suggests ongoing patent activity in:

  • Specific chemical modifications improving selectivity.
  • Combination therapies involving the patented compounds.
  • Advanced delivery systems (e.g., nanoparticles, sustained-release formulations).

These emerging fronts may influence the patent landscape’s evolution, impacting the '442 patent's strategic value.


Legal and Market Implications

The scope of the '442 patent affords the patent holder significant market exclusivity, especially if the claims are sufficiently narrow to prevent design-arounds but broad enough to cover manufacturing variants. This balance is vital for recouping R&D investments and maintaining competitive advantage.

However, the enforceability depends on the patent’s validity amidst potential challenges, including:

  • Non-obviousness based on prior art.
  • Demonstrable novelty.
  • Adequate written description and enablement.

Moreover, competitor filings and litigation can influence the patent's enforceability status.


Conclusion

The '442 patent exemplifies a strategic balance in drafting claims to secure broad chemical and therapeutic coverage while delineating specific embodiments for enforceability. Its landscape positions it as a potentially robust barrier to generic competition, subject to ongoing patent prosecution and prior art considerations.

Strategic considerations for stakeholders include:

  • Vigilant monitoring of related patents.
  • Exploring opportunities for licensing or collaboration.
  • Preparing for potential patent challenges or invalidation efforts.

An active assessment of the patent’s strength and surrounding landscape remains essential for optimizing commercial and legal strategies involving this patent.


Key Takeaways

  • The '442 patent's scope strategically covers a broad chemical class and specific therapeutic uses, establishing extensive protection.
  • Its claims balance broad molecular coverage with specific process and use claims to deter competitors.
  • The patent landscape includes similar innovations, but the '442 patent's unique features enhance its defensibility.
  • Maintaining competitiveness requires ongoing monitoring of patent filings, prior art, and legal developments.
  • Strategic patent enforcement and potential licensing are critical to maximizing commercial value.

FAQs

1. What is the primary inventive aspect covered by the '442 patent?
The patent primarily protects a specific class of novel chemical compounds with demonstrated therapeutic activity, along with their methods of synthesis and medical use, particularly for treating certain indications.

2. How broad are the claims in the '442 patent?
The independent claims are formulated to cover a wide chemical class, with dependent claims narrowing scope through specific structural features and therapeutic applications.

3. Can competitors design around this patent?
While patent claims aim to be broad, competitors can develop structural or functional variants outside the scope of the claims, especially if the patent’s language is narrowly drafted.

4. What are the main challenges to the validity of the '442 patent?
Challenges may arise from prior art disclosures of similar compounds or methods, or arguments that the invention is obvious or lacks novelty.

5. How does the patent landscape affect future market strategies?
Understanding patent overlaps and potential infringement risks allows companies to plan licensing, collaborations, or innovations that either complement or serve as design-arounds to the '442 patent.


References

  1. [Insert detailed patent citation with link or USPTO record number here]
  2. [Additional references from patent databases, known related patents, or scientific literature]

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 10,213,442

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Eirgen RAYALDEE calcifediol CAPSULE, EXTENDED RELEASE;ORAL 208010-001 Jun 17, 2016 RX Yes Yes ⤷  Get Started Free ⤷  Get Started Free Y ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.